Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph-Based Deep Learning
Yaosen Min1, Ye Wei1, Peizhuo Wang1,2
1Institute for Interdisciplinary Information Sciences, Tsinghua University, Beijing, 100084, China.
This study introduces Dynaformer, a deep learning model using molecular dynamics simulations to predict protein-ligand binding affinities. Dynaformer achieves state-of-the-art performance, accelerating drug discovery by identifying promising hit compounds.
Area of Science:
- Computational chemistry and cheminformatics
- Structural biology and drug design
- Artificial intelligence in molecular modeling
Background:
- Accurate prediction of protein-ligand binding affinities is crucial for structure-based drug design.
- Current data-driven methods are limited by reliance on static protein structures, neglecting dynamic binding ensembles.
- Molecular dynamics (MD) simulations offer a way to approximate these dynamic ensembles.
Purpose of the Study:
- To develop a deep learning model that leverages MD simulations for enhanced protein-ligand binding affinity prediction.
- To evaluate the model's performance on benchmark datasets and in virtual screening applications.
- To accelerate the early stages of drug discovery through improved computational prediction.
Main Methods:
- Curated an MD dataset of 3,218 protein-ligand complexes.
- Developed Dynaformer, a graph-based deep learning model, to learn from MD trajectories.
- Applied Dynaformer to CASF-2016 benchmark dataset for scoring and ranking evaluation.
- Conducted virtual screening on heat shock protein 90 (HSP90) and experimentally validated hit compounds.
Main Results:
- Dynaformer demonstrated state-of-the-art scoring and ranking power on the CASF-2016 benchmark.
- The model outperformed previously reported methods in binding affinity prediction.
- Virtual screening identified 20 candidate compounds for HSP90, with 12 validated as hits, including novel scaffolds.
Conclusions:
- Dynaformer effectively predicts protein-ligand binding affinities by integrating MD simulations and deep learning.
- The model shows significant promise for accelerating virtual drug screening and the early drug discovery process.
- This approach offers a powerful computational tool for identifying novel drug candidates.
More Related Videos
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
07:35A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
The Equilibrium Binding Constant and Binding Strength
Protein-protein Interfaces
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Ligand Binding and Linkage